CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

New York Health Care

New York Health Care, Inc. is a licensed home healthcare agency engaged primarily in supplying the services of paraprofessionals who provide a broad range of healthcare support services to patients in their homes. The Company operates 24 hours a day,

Eastern Dental Supplies Inc

Eastern Dental Supplies Inc is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cergis Billing

Cergis Billing is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InfuSystem Holdings

Outer Cape Health Services -Wellfleet Health Center

Outer Cape Health Services -Wellfleet Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Wellfleet, MA. To find more information about Outer Cape Health Services -Wellfleet Health Center, please visit www.outercape.org